. 2019 May 22;9:46. doi: 10.1186/s13550-019-0509-6

Table 1.

Characteristics of the 12 patients

No.	Sex	Age	Primary cancer	TNM	Stage	Metastasis	Total %ID^a	%ID/kg^b
1	F	48	Breast	T2N2M2	IV	Bone	0.025	3.00
2	M	48	Esophagus	T1N0M1	IV	Pelvis	0.001	1.41
2	M	48	Esophagus	T1N0M1	IV	Rectum	0.003	1.03
3	M	46	Liver	T3N0M1	IV	Bone	0.025	2.78
						Lung	0.004	3.56
						Liver)	2.580	9.03
4	F	61	Kidney	T4N0M1	IV	Bone	0.068	0.76
4	F	61	Kidney	T4N0M1	IV	Lung	0.001	3.22
7	F	58	Colon	T4N1M1	IV	Liver	0.017	10.12
8	F	46	Sarcoma	T2N0M1	IV	Lung	0.064	11.35
8	F	46	Sarcoma	T2N0M1	IV	Liver	0.018	7.36
9	M	66	Colon	T3N2M1	IV	Lung	0.083	3.71
10	M	63	Colon	T3N2M1	IV	Lung	0.012	2.10
11	M	64	Esophagus	T3N0M1	IV	Lung	0.061	3.99
12	M	80	Colon	T3N2M1	IV	Abdomen	0.029	1.37
						Bladder	0.040	1.10
						(Liver)	0.048	13.57
13	F	55	Colon	T4N1M1	IIIB	Lung	0.002	4.94
14	M	62	NPC	T2N1M1	IV	Lung	0.052	7.87

^aHighest tumor uptake determined from ROI on 24-h SPECT imaging

^bPercentage injected activity per kilogram calculated from estimated tumor volume